Completed PHASE4 INTERVENTIONAL 3-arm NCT01371058

Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI) (spirit)

Study of Policosanol to Improve High on Clopidogrel Platelet Reactivity After Percutaneous Coronary Stent Implantation(Spirit)

Sponsor: Shenyang Northern Hospital

Conditions Coronary Artery Disease

Interventions high maintenance clopidogrel policosanol plus dual antiplatelet routine dual antiplatelet

Updated 5 times since 2017 Last updated: Dec 15, 2015 Started: Mar 31, 2011 Primary completion: Sep 30, 2012 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Shenyang Northern Hospital and has accumulated 5 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shenyang Northern Hospital

Data source: Shenyang Northern Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenyang, China